TH138875A - Clidinium for use by inhalation in the treatment of respiratory diseases. - Google Patents
Clidinium for use by inhalation in the treatment of respiratory diseases.Info
- Publication number
- TH138875A TH138875A TH801000702A TH0801000702A TH138875A TH 138875 A TH138875 A TH 138875A TH 801000702 A TH801000702 A TH 801000702A TH 0801000702 A TH0801000702 A TH 0801000702A TH 138875 A TH138875 A TH 138875A
- Authority
- TH
- Thailand
- Prior art keywords
- patients
- therapy
- inhalation
- disease
- clidinium
- Prior art date
Links
- HOOSGZJRQIVJSZ-NNBUQUNQSA-N clidinium Chemical compound C1([C@H]2CC[N@+](CC2)(C1)C)OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 HOOSGZJRQIVJSZ-NNBUQUNQSA-N 0.000 title claims abstract 3
- 229960003154 clidinium Drugs 0.000 title claims abstract 3
- 206010038683 Respiratory disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 claims abstract 6
- 230000001022 anti-muscarinic Effects 0.000 claims abstract 4
- 238000002664 inhalation therapy Methods 0.000 claims abstract 4
- 230000001575 pathological Effects 0.000 claims abstract 4
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract 4
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 4
- ASMXXROZKSBQIH-VITNCHFBSA-N aclidinium Chemical compound C([C@@H](C(CC1)CC2)OC(=O)C(O)(C=3SC=CC=3)C=3SC=CC=3)[N+]21CCCOC1=CC=CC=C1 ASMXXROZKSBQIH-VITNCHFBSA-N 0.000 claims abstract 2
- 229940019903 aclidinium Drugs 0.000 claims abstract 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000000241 respiratory Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 1
Abstract
DC60 (08/06/55) การประดิษฐ์จัดให้มีวิธีการของการบำบัดโดยการสูดสำหรับโรคหรือสภาวะของทางเดิน หายใจในผู้ป่วยที่มีความต้องการการบำบัดดังกล่าว โดยปราศจากการสร้างผลกระทบแอนตีมัสคารินิค ทางระบบดังที่ได้กล่าวไว้แล้ว, ประกอบด้วยการให้แก่ผู้ป่วยดังที่ได้กล่าวไว้ด้วยปริมาณที่มี ประสิทธิภาพของอะคลิดิเนียม (Aclidinium) การประดิษฐ์จัดให้มีวิธีการของการบำบัดโดยการสูดสำหรับโรคหรือสภาวะของทางเดิน หายใจในผู้ป่วยที่มีความต้องการบำบัดดังกล่าว โดยปราศจากการสร้างผลกระทบแอนตีมัสคารินิค ทางระบบดังที่ได้กล่าวไว้แล้ว, ประกอบด้วยการให้แก่ผู้ป่วยดังกล่าวไว้ด้วยปริมาณที่มี ประสิทธิภาพของอะคลิดิเนียม สิทธิบัตรยา DC60 (08/06/55) The invention provides a method of inhalation therapy for disease or pathological conditions. Breathing in patients with a need for such therapy Without creating an antimuscarinic effect The system as mentioned above, consists of giving to the aforementioned patients with available doses. Efficacy of Clidinium (Aclidinium) Invention provides a method of inhalation therapy for disease or pathological conditions. Breathing in patients who need such therapy Without creating an antimuscarinic effect The system as mentioned above, consists of providing the aforementioned patients with available doses. The efficacy of acrylic, drug patent
Claims (2)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH0801000702A TH0801000702A (en) | 2015-01-16 |
| TH138875A true TH138875A (en) | 2015-01-16 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA98136C2 (en) | Use of aclidinium for the treatment of respiratory diseases | |
| MX2011013902A (en) | Treatment of multiple sclerosis with laquinimod. | |
| CY1111359T1 (en) | Memantine for the treatment of mild to moderate ALZHEIMER | |
| EA201390827A1 (en) | USE OF LAKININIMODE TO REDUCE FATIGUE, IMPROVE FUNCTIONAL CONDITION AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH MULTIPLE SCLEROSIS | |
| NO20064964L (en) | Treatment of impaired respiratory function | |
| EA201590655A8 (en) | COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| NO20054180D0 (en) | Treatment of bacterial diseases of the respiratory tract by local administration of fluoroquinolones | |
| TW200740452A (en) | Therapeutic gastrodia extracts | |
| EA201590933A1 (en) | NEW ORAL BIO-ACCESSIBLE CONNECTIONS, MODULATING RESPIRATION CONTROL, AND METHODS OF THEIR USE | |
| EA201270071A1 (en) | A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT | |
| CY1110369T1 (en) | NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol | |
| BRPI0804623A2 (en) | use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive impairment | |
| AU2018253538A1 (en) | Levodopa formulations for rapid relief of parkinson's disease | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| MA27538A1 (en) | SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND (R, R) -FORMOTEROL | |
| TH138875A (en) | Clidinium for use by inhalation in the treatment of respiratory diseases. | |
| MX2021007324A (en) | Oral therapy using 6,8-bis-benzylthio-octanoic acid. | |
| ATE495750T1 (en) | SULFATIDES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | |
| WO2013181217A3 (en) | Novel compounds and compositions for treatment of breathing control disorders or diseases | |
| MX2021004656A (en) | Reducing inter-patient variability of levodopa plasma concentrations. | |
| RU2008107113A (en) | MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE | |
| Tate de Stanley et al. | On a transitory clinical trap during the first session. Study of the intersubjectivity using David Liberman algorithm (DLA) | |
| WO2009071725A3 (en) | Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease | |
| RU2012126230A (en) | METHOD FOR ASSESSING THE RESPIRATORY ORGANIC STATE IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE AND INFLUENCE ON WELL-BEING AND EVERYDAY LIFE | |
| UA27224U (en) | Method for regulating respiration |